25.04.2013 Views

Anno 2005 - Vol 13 - N° 3 - AIDA

Anno 2005 - Vol 13 - N° 3 - AIDA

Anno 2005 - Vol 13 - N° 3 - AIDA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

. - CI)<br />

c<br />

CI)<br />

c<br />

u<br />

«<br />

Luglio-Serrembre <strong>2005</strong><br />

umero 3<br />

24 Leyden J, Bergfeld W, Drake L, e colI. A systemic type I 5 alpha-reductase inhibitor is ineffective in<br />

me treatment of acne vulgaris. \<br />

25 ZOllboulis Che. Saborowski A, Boschnakow A. Zileuton, an oral 5-lipoxygenase inhibitor, direcdy<br />

reduces sebum production. Dermatology. <strong>2005</strong>;210(1):36-8.<br />

26 Cunliffe WJ, Holland DB, Clark SM, Stabies G1. Comedogenesis: some aetiological, clinical and<br />

therapeutic strategies. Dermatology. 2003;206(1): 11-6 .<br />

27 Jappe U. Pamological mechanisms of acne wim special emphasis on Propionibacterium acnes and<br />

related therapy. Acta Derm Venereo\. 2003;83(4):241-8. Review.<br />

28 Toyoda M , Motohashi M. New aspects in acne inflammation. Dermatology. 2003;206(1):17-23.<br />

29 Graham GM, Farrar MD, Cruse- awyer JE, e colI. Proinflammatory cytokine prodllction by human.<br />

keratinocytes stimulated with Propionibacterium aenes and P. aenes GroEL. Br J Dermatol. 2004<br />

Mar; 150(3):421-8.<br />

30 Pivaresi A, Bodai L, Rethi B, Kenderessy-Szabo A, Koreck A, e collo Expression and function of Tolllike<br />

receptors 2 and 4 in hllman keratinocytes. Int Immuno\. 2003 Jun;15(6):721-30.<br />

31 Jumau cir. in Dreno B, JDP dic .. 2004 in press Br J Derm.<br />

32 Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, e col\. Activation of toll-like receptor 2 in<br />

acne triggers inflammatory cytokine responses. J Immunol. 2002 Aug 1;169(3):1535-41.<br />

33 chmum M , H aqq CM, Caims WJ, Holder JC, Dorsain S, e col\. Peroxisome proliferator-activated<br />

receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes. J<br />

Invest Dermatol. 2004 Apr; 122(4):971-83. Oct; 123(4):806.<br />

34 Downie MM, anders DA, Kealey T. Modelling the remission of individual acne le ions in vitro Br<br />

J Dermatol. 2002 Nov; 147(5):869-78.<br />

35 Jeremy AH, Holland DB, Roberrs SG, Thomson KF, Cunìiffe WJ,<br />

Inflammatory events are involved in acne lesion initiation. J Invest Dermatol. 2003 Jul; 121(1):20-7.<br />

36 Koreck A, Pivaresi A, Dobozy A, Kemeny L. The role of innate immunity in the pathogenesis of acne.<br />

D ermatology. 2003;206(2):96-105<br />

37 Jemec GB, Jemec B. Acne: treatment of scarso Clin Dermatol. 2004 Sep-Oct;22(5):434-8<br />

38 Holland DB, Jeremy AH, Roberrs SG, Seukeran DC, Layton AM, Cunliffe WJ. Inflammation in<br />

acne scarring: acomparison of the responses in lesions from patients prone and not prone to scar. Br<br />

J D ermatol. 2004 Jan; 150(1):72-8 1.<br />

39 Maddin WS, Landells ID, Poulin Y, Searles GE, Smith KC, Tan JK e coll, Treatment of acne vulgaris<br />

and prevention of acne scarring: canadian consensus guidelines. J Curan Med Surg. 2000 JlIn; 4<br />

Suppll: 2-<strong>13</strong>.<br />

40 Mandekou-Lefaki l, Delli F, Teknetzis A, Eurhimiadou R, Karakatsanis G. Low-dose schema ofisorretinoin<br />

in acne vulgaris. Int J Clin Pharmacol Res. 2003;23(2-3):41-6.<br />

41 Chiu A, Chon Y, Kimball AB. The response of skin disease to stress: changes in the severity of acne<br />

vulgaris as affected by examination stress. Arch Dermatol. 2003 Jul;<strong>13</strong>9(7) :897-900.<br />

42 Toyoda M, Nakainura M, Morohashi M. Neuropeptides and sebaceous glands. Eur J Dermarol.<br />

2002 ep-Oct; 12(5):422-7<br />

43 Zouboulis Cc, Bohm M. Neuroendocrine reguiation of sebocytes -- a pathogenetic link berween<br />

stress and acne. Exp Dermato\. 2004; <strong>13</strong> Suppl 4:3 I -5.<br />

44 Pelfìni C, Vignini M, Palestra M, Ferretti M. L'acne e un viso sorridente. Monografìa 1989.<br />

45 Pancone i E. Lo stress, le emozioni, la pelle. Milano, Masson, 1989.<br />

46 Cunliffe WJ. Unemployment and acne. Br J Dermatol 1986; l 15:3 86<br />

47 Vanagr WY, Daenen WJ, Delhaas T. Rapp DA, Brenes GA, Feldman R, Fleischer AB Jr, Graham<br />

GF, Dailey M, Rapp R. Anger and acne: implications for quality of life, patient satisfaction and clinical<br />

care. Br J Dermatol. 2004 Jul; 151(1):183-9.<br />

48 Cribier B. Acné et qualité de la vie. Ann Dermatol Venereol 2000; 127:2S<strong>13</strong>-2s14<br />

49 Bassi R. Acne malattia psicosomatica. Dermatologia oggi. n 1. 1993<br />

50 Schafer T, Nienhaus A, Vieluf D , Berger J, Ring J. Epidemiology of acne in the general population:<br />

the risk of smoking, Br J Dermatol. 2001 Jul; 145(1): 100-4.<br />

51 Jemec GB, Linneberg A, Nicisen NH, Frolund L, Madsen F, Jorgensen T. Have oral contraceptives<br />

reduced the prevalence of acne? A population-based srudy of acne vulgaris, tobacco smoking and oral<br />

contraceptives. Dermatology. 2002; 204(3): 179-84.<br />

52 Pelfìni C, Carlini L, Ghelli E, Solaroli e. Perché tanto sole (e fototerapia) nell'acne? Giornale Italiano<br />

di Dennatologia e Venereologia 199 1; 126:337-343.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!